

AOD9604 5mg is a research-grade lyophilized peptide consisting of the 176-191 fragment of human growth hormone (HGH). It is extensively investigated in laboratory settings for growth hormone fragment biology, peptide pharmacology, receptor-mediated signaling, and metabolic pathway research. Every batch undergoes analytical verification to support purity, consistency, and reproducibility for advanced scientific investigations.
HPLC certified
Independent analysis
Highest standard
Full traceability
AOD9604 5mg is an investigational synthetic peptide derived from the C-terminal 176-191 amino acid sequence of human growth hormone (HGH). Unlike full-length growth hormone, AOD9604 enables researchers to investigate biological activities associated with this specific peptide fragment while examining receptor interactions, intracellular signaling pathways, peptide engineering, and molecular pharmacology under controlled laboratory conditions. Its unique molecular design has established it as an important investigational compound within growth hormone fragment research.
The 5mg presentation is well suited for receptor pharmacology studies, peptide characterization, assay development, comparative growth hormone fragment investigations, and analytical method validation. Researchers continue evaluating AOD9604's molecular stability, receptor-binding characteristics, intracellular signaling mechanisms, and peptide-receptor interactions to better understand the biological properties of HGH-derived peptide fragments. Manufactured according to research-grade quality standards and supported by comprehensive analytical verification, AOD9604 5mg provides laboratories with a dependable investigational peptide for advanced molecular and endocrine research.
AOD9604 5mg is a research-grade synthetic peptide representing the 176-191 amino acid fragment of human growth hormone (HGH). Through selective peptide engineering, this fragment was developed to allow researchers to investigate specific molecular characteristics associated with the C-terminal region of growth hormone independently from the complete hormone structure. This unique molecular design has made AOD9604 an important investigational compound for laboratories studying growth hormone fragment biology, peptide pharmacology, receptor-mediated signaling, and molecular endocrinology.
Unlike recombinant human growth hormone or other growth hormone-derived peptides, AOD9604 represents only a small functional region of the native HGH molecule. Researchers utilize this peptide to investigate fragment-specific biological mechanisms, receptor interactions, intracellular signaling pathways, ligand-binding characteristics, peptide stability, and molecular communication under carefully controlled laboratory conditions. These investigations contribute to expanding scientific understanding of how individual growth hormone domains influence peptide biology.
Current scientific investigations continue exploring intracellular signaling pathways associated with AOD9604. Laboratory studies examine receptor activation, cyclic adenosine monophosphate (cAMP) signaling, kinase activation, intracellular trafficking, second messenger communication, transcriptional regulation, peptide metabolism, and molecular adaptation following peptide-receptor interaction. These investigations provide valuable insight into growth hormone fragment biology and peptide-mediated cellular communication.
AOD9604 is also widely investigated within comparative peptide pharmacology. Researchers frequently compare its molecular properties with investigational peptides including CJC-1295, Ipamorelin, Tesamorelin, Sermorelin, and full-length recombinant human growth hormone to better understand differences in molecular architecture, receptor interactions, peptide engineering strategies, and biological signaling characteristics. These comparative investigations continue supporting the evolution of peptide-based research models.
The 5mg presentation is particularly appropriate for laboratories conducting receptor pharmacology studies, peptide characterization, analytical method validation, assay development, biomarker investigations, and long-term scientific research. Although additional strengths may be available for larger experimental workflows, the molecular identity, analytical quality, receptor pharmacology, and scientific applications remain consistent across all AOD9604 presentations.
Beyond receptor biology, AOD9604 serves as an important analytical reference material in ligand-binding studies, analytical chemistry, peptide stability investigations, pharmacodynamic research, molecular characterization, biomarker evaluation, and assay optimization. Its well-characterized molecular structure and reproducible analytical profile make it a valuable investigational peptide for advanced laboratory research.
Each batch of AOD9604 5mg is manufactured according to research-grade production standards and undergoes comprehensive analytical verification before release. Quality assurance procedures include High-Performance Liquid Chromatography (HPLC) purity analysis, molecular identity confirmation, and rigorous batch-specific quality control testing. These analytical measures help ensure reproducibility, consistency, and confidence across independent laboratory investigations.
To preserve molecular integrity, AOD9604 should be stored and handled according to accepted laboratory procedures for lyophilized peptides. Appropriate storage conditions, controlled handling practices, and adherence to established laboratory protocols help maintain peptide stability before analytical evaluation and experimental preparation.
Although significant progress has been made in characterizing AOD9604's molecular properties, scientific investigations continue to explore receptor regulation, intracellular signaling dynamics, peptide engineering, molecular adaptation, and growth hormone fragment biology. Consequently, AOD9604 5mg should be regarded as an investigational research compound intended exclusively to support laboratory research and scientific discovery.
AOD9604 5mg is supplied exclusively for laboratory research and analytical applications. This product is intended for Research Use Only (RUO) and is not approved for human consumption, therapeutic use, veterinary applications, or diagnostic purposes.

AOD9604 vs CJC-1295: see what published clinical trials actually found on fat loss, GH/IGF-1 effects, safety, and U.S. regulatory status.

A research overview of AOD9604's beta-3 receptor mechanism, its discontinued Phase 2b trial, cartilage research, and WADA/FDA status.

Semaglutide vs tirzepatide for weight loss — compare efficacy, side effects & cost using real clinical trial data. Read the full comparison now.
(faqs)